StockData
Aytu BioPharma, Inc logo

Aytu BioPharma, Inc (AYTU) stock

AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3070% below fair value
$2.66+0.00 (0.00%)

Close on Nov 20, 2026Market cap $28.91MP/E –Yield –

Aytu BioPharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Aytu BioPharma's free cash flow for the twelve months ending Jun 30, 2026 was $3.25M. For fiscal 2026 it was $3.25M. The highest annual figure on record is $3.25M in fiscal 2026.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026$3.25M–
FY2025Jun 30, 2025-$2.17M–
FY2024Jun 30, 2024-$1.72M–
FY2022Jun 30, 2022-$28.82M–
FY2021Jun 30, 2021-$28.31M–
FY2020Jun 30, 2020-$28.37M–
FY2019Jun 30, 2019-$13.89M–
FY2018Jun 30, 2018-$16.02M–
FY2017Jun 30, 2017-$13.94M–
FY2016Jun 30, 2016-$10.91M–
FY2015Jun 30, 2015-$6.63M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$4.39M+57.7%
Q3 FY2026CQ1 2026Mar 31, 2026-$4.18M–
Q2 FY2026CQ4 2025Dec 31, 2025$3.66M+26.2%
Q1 FY2026CQ3 2025Sep 30, 2025-$618.00K–
Q4 FY2025CQ2 2025Jun 30, 2025$2.79M–
Q3 FY2025CQ1 2025Mar 31, 2025-$6.52M–
Q2 FY2025CQ4 2024Dec 31, 2024$2.90M-57.2%
Q1 FY2025CQ3 2024Sep 30, 2024-$1.33M–
Q4 FY2024CQ2 2024Jun 30, 2024-$1.12M-105.8%
Q3 FY2024CQ1 2024Mar 31, 2024-$254.00K–
Q4 FY2021CQ2 2021Jun 30, 2021$6.78M–
Q4 FY2020CQ2 2020Jun 30, 2020-$1.91M–
Q3 FY2020CQ1 2020Mar 31, 2020$19.25M–
Q2 FY2020CQ4 2019Dec 31, 2019-$10.60M–
Q1 FY2020CQ3 2019Sep 30, 2019-$2.99M–
Q4 FY2019CQ2 2019Jun 30, 2019-$3.47M–
Q3 FY2019CQ1 2019Mar 31, 2019-$3.36M–
Q2 FY2019CQ4 2018Dec 31, 2018-$4.31M–
Q1 FY2019CQ3 2018Sep 30, 2018-$2.75M–
Q4 FY2018CQ2 2018Jun 30, 2018-$4.54M–
Q3 FY2018CQ1 2018Mar 31, 2018-$4.14M–
Q4 FY2017CQ2 2017Jun 30, 2017-$3.33M–
Q3 FY2017CQ1 2017Mar 31, 2017-$2.40M–
Q2 FY2017CQ4 2016Dec 31, 2016-$2.88M–
Q1 FY2017CQ3 2016Sep 30, 2016-$5.34M–

More Aytu BioPharma figures

See a number that looks wrong?